[1]
“ANALYSIS OF FINANCIAL PERFORMANCE OF PHARMACY COMPANIES DURING THE COVID-19 PANDEMIC”, unita, vol. 5, pp. 340–347, Dec. 2023, doi: 10.36563/proceeding.v5i0.136.